Lonafarnib

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 280 publications

Inhibitory effect of lonafarnib on anaplastic thyroid carcinoma cell lines and a nude mouse xenograft model

Inhibitory effect of lonafarnib on anaplastic thyroid carcinoma cell lines and a nude mouse xenograft model

Journal: Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences

Published: June 08, 2026

Increased Telomere Mobility in Progeria is Restored by Isoprenylcysteine Carboxyl Methyltransferase Inhibition.

Increased Telomere Mobility in Progeria is Restored by Isoprenylcysteine Carboxyl Methyltransferase Inhibition.

Journal: bioRxiv : the preprint server for biology

Published: May 07, 2026

Hepatitis D in the Middle East: A Review of Disease Burden, Health-System Barriers, and Strategic Directions for Management and Elimination.

Hepatitis D in the Middle East: A Review of Disease Burden, Health-System Barriers, and Strategic Directions for Management and Elimination.

Journal: Cureus

Published: May 03, 2026

Renaissance of farnesyltransferase inhibitors in cancer.

Renaissance of farnesyltransferase inhibitors in cancer.

Journal: Journal of translational medicine

Published: February 23, 2026

Lonafarnib for chronic hepatitis delta: Clinical mechanism of action, development, and evolving role in combination therapy.

Lonafarnib for chronic hepatitis delta: Clinical mechanism of action, development, and evolving role in combination therapy.

Journal: Antiviral research

Published: February 19, 2026

Mapping the landscape of Hutchinson-Gilford Progeria Syndrome research: A bibliometric analysis (1995-2025).

Mapping the landscape of Hutchinson-Gilford Progeria Syndrome research: A bibliometric analysis (1995-2025).

Journal: Ageing research reviews

Published: January 21, 2026

Biomarkers and therapies Associated with Hutchinson-Gilford Syndrome.

Biomarkers and therapies Associated with Hutchinson-Gilford Syndrome.

Journal: Ageing research reviews

Published: January 21, 2026

Comparative Efficacy of Bulevirtide, Interferons, and Nucleos(t)ide Analogs for Chronic Hepatitis Delta: A Systematic Review and Network Meta-Analysis.

Comparative Efficacy of Bulevirtide, Interferons, and Nucleos(t)ide Analogs for Chronic Hepatitis Delta: A Systematic Review and Network Meta-Analysis.

Journal: International journal of hepatology

Published: December 22, 2025

Molecular mechanism of resistance to lonafarnib conferred by mutations in the cysteine-rich region of respiratory syncytial virus fusion glycoprotein and discovery of a lonafarnib-derived antiviral PROTAC.

Molecular mechanism of resistance to lonafarnib conferred by mutations in the cysteine-rich region of respiratory syncytial virus fusion glycoprotein and discovery of a lonafarnib-derived antiviral PROTAC.

Journal: Journal of virology

Published: December 09, 2025

Heat stroke-induced structural and functional impairments of cognition-relevant brain areas in mice is associated with alpha-7 nicotinic acetylcholine receptors downregulation.

Heat stroke-induced structural and functional impairments of cognition-relevant brain areas in mice is associated with alpha-7 nicotinic acetylcholine receptors downregulation.

Journal: European journal of pharmacology

Published: November 28, 2025

Inhibition of farnesyltransferase activity diminishes hematopoietic stem cell ex vivo expansion ability.

Inhibition of farnesyltransferase activity diminishes hematopoietic stem cell ex vivo expansion ability.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Targeted Sensitization of Leukemic T-cells to Anticancer Drugs by SIRT1 Agonist SRT-1720.

Targeted Sensitization of Leukemic T-cells to Anticancer Drugs by SIRT1 Agonist SRT-1720.

Journal: Anticancer research

Published: November 19, 2025

Showing 1-12 of 280

Last Updated: 06/30/2026